Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

Aim. To determine the value of polymorphisms of the immune response genes for the treatment efficacy in MM patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation (autoHSCT). Methods. The overall of 20 ММ patients (8 men and 12 women) were included in the...

Full description

Bibliographic Details
Main Authors:	EL Nazarova, NV Minaeva, MN Khorobrykh, EE Sukhorukova, VI Shardakov, IV Paramonov, NA Zorina
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2018-01-01
Series:	Kliničeskaâ onkogematologiâ
Subjects:	multiple myeloma gene polymorphisms immune response cytokine Toll-like receptor high-dose chemotherapy autologous hematopoietic stem cell transplantation
Online Access:	http://bloodjournal.ru/wp-content/uploads/2018/01/7.pdf

Similar Items

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
by: Nikita E. Mochkin, et al.
Published: (2020-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Efficacy and prognostic factors of autologous hematopoietic stem cell transplantation for multiple myeloma: clinical analysis of 53 cases
by: HE Renke, et al.
Published: (2021-03-01)

Effect of bortezomib on the efficiency of hematopoietic stem cell mobilization in patients with multiple myeloma
by: O S Pokrovskaia, et al.
Published: (2012-07-01)

Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual disease
by: M V Solovyev, et al.
Published: (2017-07-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
by: Rahul Naithani, et al.
Published: (2020-10-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)

Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review
by: Marco Aurélio Salvino, et al.
Published: (2016-02-01)

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients
by: M. V. Solovev, et al.
Published: (2019-01-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

O transplante autólogo de células-tronco hematopoéticas no tratamento do Mieloma Múltiplo Autologous hematopoietic stem cell transplant for Multiple Myeloma
by: Angelo Maiolino, et al.
Published: (2007-03-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis
by: Malgorzata Wach, et al.
Published: (2011-07-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma
by: Giulia Di Lullo, et al.
Published: (2019-01-01)

Autologous hematopoietic transplantation following COVID‐19 infection
by: Marthilde Brzycki, et al.
Published: (2021-03-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation &#8212; a fresh analysis
by: Anna Dmoszynska, et al.
Published: (2011-07-01)

Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma
by: Lázár Erzsébet, et al.
Published: (2016-12-01)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
by: Simone A. Minnie, et al.
Published: (2021-03-01)

Double Hematological and Cardiologic Benefits of Autologous Stem Cell Transplantation in a Case of stage III B IgG Myeloma multiplex and Dilatative Cardiomyopathy – a Case Report
by: Erzsebet Benedek Lazar, et al.
Published: (2015-11-01)

Multiple myeloma
by: Larisa P. Mendeleeva, et al.
Published: (2021-02-01)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
by: Lakshmi Yarlagadda, et al.
Published: (2021-08-01)

PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients
by: M V Solovev, et al.
Published: (2019-07-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013-02-01)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
by: Malkan Umit Yavuz, et al.
Published: (2021-01-01)

Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas
by: VO Sarzhevskii, et al.
Published: (2019-03-01)

Pretransplant Determinants of Outcome in Patients with Myeloma Undergoing Autologous Transplantation in Lower Resource Settings
by: Chandran Nair
Published: (2021-06-01)

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
by: Marc-Andrea Baertsch, et al.
Published: (2021-09-01)

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
by: Edvan de Queiroz Crusoe, et al.
Published: (2014-01-01)

Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery
by: NE Mochkin, et al.
Published: (2018-07-01)

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
by: VO Sarzhevskii, et al.
Published: (2016-10-01)

Herpes zoster after autologous hematopoietic stem cell transplantation
by: Kelli Borges dos Santos, et al.

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
by: Sevgisun Kapucu, et al.
Published: (2014-01-01)

Changes in serologic markers of hepatitis B in autologous hematopoietic stem cell transplantation recipients
by: Mehmet Hilmi Dogu, et al.
Published: (2016-01-01)